Literature DB >> 15242959

Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases.

Boulos Maraha1, Martin den Heijer, Jan Kluytmans, Marcel Peeters.   

Abstract

We assessed the impact of five serologic tests on the link between Chlamydia pneumoniae and abdominal aortic aneurysms (AAA). The results of the tests were inconsistent. Agreement among the five tests was generally poor. Detection of the link between C. pneumoniae and AAA depends on the serologic methodology chosen.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15242959      PMCID： PMC440624          DOI： 10.1128/CDLI.11.4.789-791.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  14 in total

1.  Detection of Chlamydia pneumoniae DNA in buffy-coat samples of patients with abdominal aortic aneurysm.

Authors:  B Maraha; M den Heijer; M Wullink; A van der Zee; A Bergmans; H Verbakel; M Kerver; S Graafsma; S Kranendonk; M Peeters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-02       Impact factor: 3.267

2.  Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results.

Authors:  R W Peeling; S P Wang; J T Grayston; F Blasi; J Boman; A Clad; H Freidank; C A Gaydos; J Gnarpe; T Hagiwara; R B Jones; J Orfila; K Persson; M Puolakkainen; P Saikku; J Schachter
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

Review 3.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Authors:  S F Dowell; R W Peeling; J Boman; G M Carlone; B S Fields; J Guarner; M R Hammerschlag; L A Jackson; C C Kuo; M Maass; T O Messmer; D F Talkington; M L Tondella; S R Zaki
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

4.  Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results?

Authors:  Daisy G M Bloemenkamp; Willem P Th M Mali; Frank L J Visseren; Yolanda van der Graaf
Journal:  Am Heart J       Date:  2003-03       Impact factor: 4.749

5.  Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals.

Authors:  A Schumacher; A B Lerkerød; I Seljeflot; L Sommervoll; I Holme; J E Otterstad; H Arnesen
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Evaluation of a commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci.

Authors:  K Persson; S Haidl
Journal:  APMIS       Date:  2000-02       Impact factor: 3.205

7.  Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; Y Wong; M Bernardes-Silva; M Ward
Journal:  BMJ       Date:  2000-07-22

8.  Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.

Authors:  Corinna Hermann; Kathrin Graf; Annemarie Groh; Eberhard Straube; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.

Authors:  L A Jackson; J D Cherry; S P Wang; J T Grayston
Journal:  Clin Infect Dis       Date:  2000-07-17       Impact factor: 9.079

10.  Molecular evidence for the existence of additional members of the order Chlamydiales.

Authors:  Jacobus M Ossewaarde; Adam Meijer
Journal:  Microbiology       Date:  1999-02       Impact factor: 2.777
View more
  3 in total

Review 1.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology.

Authors:  B Falkensammer; C Duftner; R Seiler; M Pavlic; G Walder; D Wilflingseder; H Stoiber; P Klein-Weigel; M Dierich; G Fraedrich; R Würzner; M Schirmer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

Review 3.  Circulating markers of abdominal aortic aneurysm presence and progression.

Authors:  Jonathan Golledge; Philip S Tsao; Ronald L Dalman; Paul E Norman
Journal:  Circulation       Date:  2008-12-02       Impact factor: 29.690
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.